Skip to main content

Table 3 Differentially regulated genes (probe sets) in responders and nonresponders

From: Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept

Symbol

Accession number

Probe set

Function

J value

Directiona

Significanceb

Transcription/regulation of transcription

      

   TNFAIP3

AI738896

202643_s_at

TNFα-induced protein 3

1.1830

-

+

   TNFAIP3

NM_006290

202644_s_at

TNFα-induced protein 3

0.9956

-

+

   NFKBIA

AI078167

201502_s_at

NFκB enhancer in B-cell inhibitor alpha

0.4762

-

+

   RUNX1

L21756

211620_x_at

Runt-related transcription factor 1

0.3940

+

+

   JUN

BG491844

201464_x_at

c-jun proto-oncogene

0.1352

-

-

   ZFP36L2

AI356398

201367_s_at

Zinc finger protein 36, C3H type-like 2

0.1308

-

+

   SRRM2

AI655799

208610_s_at

Serine/arginine repetitive matrix 2

0.0081

+

-

   ASCL1

AW950513

213768_s_at

Achaete-scute complex-like 1

0.0444

-

-

   FOXO3A

AF041336

210655_s_at

Forkhead box O3A

0.0131

-

-

Immune response

      

   IL1B

NM_000576

205067_at

IL-1β

0.9716

-

+

   IL1B

M15330

39402_

IL-1β

0.9523

-

+

   CCL4

NM_002984

204103_at

Chemokine (C-C motif) ligand 4

0.8002

-

+

   CCL3

NM_002983

205114_s_at

Chemokine (C-C motif) ligand 3

0.4621

-

+

   CXCR4

AF348491

211919_s_at

Chemokine (C-X-C motif) receptor 4

0.2589

-

-

   CXCL2

M57731

209774_x_at

Chemokine (C-X-C motif) ligand 2

0.2532

-

+

   LTF

NM_002343

202018_s_at

Lactotransferrin

0.1884

-

-

   PBEF1

NM_005746

217739_s_at

Pre-B-cell colony-enhancing factor 1

0.0751

-

-

   IGHA1

S55735

217022_s_at

Immunoglobulin heavy constant alpha 1

0.0475

-

-

   IER3

NM_003897

201631_s_at

Immediate early response 3

0.0284

-

-

Receptors, cell surface antigens, cell adhesion

      

   ADAM12

AU145357

215613_at

ADAM metallopeptidase domain 12 (meltrin alpha)

0.5538

-

+

   ICAM1

AI608725

202637_s_at

Intercellular adhesion molecule 1 (CD54)

0.5399

-

-

   SCN2B

U87555

210364_at

Sodium channel, voltage-gated, type II, beta

0.2294

+

+

Signal transduction

      

   PDE4B

L20966

211302_s_at

Phosphodiesterase 4B, cAMP-specific

0.4374

-

+

   RAPGEF1

NM_005312

204543_at

Rap guanine nucleotide-exchange factor 1

0.2890

-

+

   MYO10

AI1561354

216222_s_at

Myosin X

0.2066

-

+

   PTPRD

NM_002839

205712_at

Protein tyrosine phosphatase, receptor type, D

0.1822

+

+

   SOCS1

AI056051

209999_x_at

Suppressor of cytokine signaling 1

0.1239

-

-

   PDE4B

NM_002600

203708_at

Phosphodiesterase 4B, cAMP-specific

0.0593

-

+

Metabolism

      

   LGALS13

NM_013268

220440_at

Lectin, galactose-binding, soluble, 13 (galectin 13)

0.5013

+

+

   SNCA

BG260394

204466_s_at

Synuclein, alpha

0.0568

-

-

   CHST3

AB017915

32094_at

Carbohydrate sulfotransferase 3

0.0366

-

+

Cellular and oxidative stress response

      

   CROP

AW089673

208835_s_at

Cisplatin resistance-associated overexpressed protein

0.7500

+

+

   PPP1R15A

NM_014330

202014_at

Protein phosphatase 1, regulatory (inhibitor) subunit 15A

0.6886

-

+

   PPP1R15A

U83981

37028_at

Protein phosphatase 1, regulatory (inhibitor) subunit 15A

0.5939

-

-

   DDIT4

M_019058

202887_s_at

DNA-damage-inducible transcript 4

0.2366

-

-

   SOD2

W46388

215223_s_at

Superoxide dismutase 2, mitochondrial

0.0724

-

-

   ADM

NM_001124

202912_at

Adrenomedullin

0.0459

-

+

Transport

      

   ATP2A3

AF068220

207521_s_at

ATPase, Ca2+ transporting, ubiquitous

0.227

-

-

   CHRND

NM_000751

207024_at

Cholinergic receptor, nicotinic, delta

0.1977

-

+

Protein binding

      

   PIGO

AC004472

214990_at

Phosphatidylinositol glycan, class O

0.5216

-

+

   IBRDC3

W27419

36564_at

IBR domain containing 3

0.1194

-

+

   EBP49

NM_001978

204505_s_at

Erythrocyte membrane protein band 4.9 (dematin)

0.0804

-

-

   FBX07

NM_012179

201178_at

F-box protein 7

0.0080

-

-

Unknown

      

   FSD1

NM_024333

219170_at

Fibronectin type III and SPRY domain containing 1

0.2935

-

+

   HCG4P6

AF036973

215974_at

HLA complex group 4 pseudogene 6

0.1518

-

+

   C20orf103

NM_013361

219463_at

Chromosome 20 open reading frame 103

0.0022

-

-

  1. Genes were identified as differentially regulated using a modified t-statistic score, J (see Additional file 1), calculated using signal log ratios at t1 versus t0 considering 12 responders and seven nonresponders to etanercept therapy. aDirection denotes genes as stronger downregulated or lesser upregulated in responders compared with nonresponders (-), and vice versa (+). b+, significance approved by the resampling method with the modified t statistic on the significance level α = 0.05 (see Data processing and analysis section).